ArticlePharmacology research & perspectives2020

Ibrutinib does not have clinically relevant interactions with oral contraceptives or substrates of CYP3A and CYP2B6.

Jan de Jong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.